Literature DB >> 10529944

Work-related upper-extremity disorders: prospective evaluation of clinical and functional outcomes.

G Pransky1, K Benjamin, J Himmelstein, K Mundt, W Morgan, M Feuerstein, K Koyamatsu, C Hill-Fotouhi.   

Abstract

The purpose of this study was to describe the demographic, vocational, medical, workplace, and psychosocial characteristics of patients treated for work-related upper-extremity disorders, to document treatment patterns in a community-practice setting, and to determine which of these factors predicts subsequent employment and functional status outcomes. A questionnaire was administered by mail or telephone to 112 patients seen at the University of Massachusetts Occupational Upper Extremities Disorders Clinic and included measures of disease-specific functional status, pain, reactions to pain, employer-employee relations, and number and type of interventions used to treat the disorder. Results were compared with baseline data obtained, on average, 16 months prior to follow-up. Of the original cohort (n = 124), 112 participated in the prospective study. Although most patients reported improvement in pain severity, fear of pain, life situation, and functional status, there was little change in employment status. Patients' self-reported intentions of return to work at baseline did not predict work status at follow-up. In general, those who were employed at baseline remained employed, had a greater reduction in symptom severity over time, and were significantly more likely to report improvement in their problem than those who were unemployed. The efficacy of various interventions was examined by type, mix, and intensity (number of different interventions undergone by the patient). No positive relationship was found between these measures and employment status, self-reported change in the problem, or self-reported improvement in functional status. Significant negative relationships were found between surgery, psychotherapeutic interventions, and outcomes. This was likely to have occurred because of a selection bias toward the more chronic and severely disabled patients for these treatments. However, the relative ineffectiveness of such intensive interventions as surgery in improving the work and health status of chronically symptomatic work-related upper-extremity patients cannot be overlooked. The findings suggest that more emphasis be placed on interventions aimed at resolving differences between employers and injured employees. More careful selection of patients for expensive and invasive procedures is recommended.

Entities:  

Mesh:

Year:  1999        PMID: 10529944     DOI: 10.1097/00043764-199910000-00009

Source DB:  PubMed          Journal:  J Occup Environ Med        ISSN: 1076-2752            Impact factor:   2.162


  5 in total

1.  Muscle learning therapy--efficacy of a biofeedback based protocol in treating work-related upper extremity disorders.

Authors:  S Nord; D Ettare; D Drew; S Hodge
Journal:  J Occup Rehabil       Date:  2001-03

Review 2.  Readiness for return to work following injury or illness: conceptualizing the interpersonal impact of health care, workplace, and insurance factors.

Authors:  Renée-Louise Franche; Niklas Krause
Journal:  J Occup Rehabil       Date:  2002-12

3.  Improving return to work research.

Authors:  Glenn Pransky; Robert Gatchel; Steven J Linton; Patrick Loisel
Journal:  J Occup Rehabil       Date:  2005-12

4.  Translation, cross-cultural adaptation and psychometric properties of Urdu version of upper limb functional index; a validity and reliability study.

Authors:  Ayesha Arooj; Fareeha Amjad; Fahad Tanveer; Asad Ullah Arslan; Ashfaq Ahmad; Syed Amir Gilani
Journal:  BMC Musculoskelet Disord       Date:  2022-07-20       Impact factor: 2.562

5.  Predictors of upper extremity symptoms and functional impairment among workers employed for 6 months in a new job.

Authors:  Bethany T Gardner; Ann Marie Dale; Linda VanDillen; Alfred Franzblau; Bradley A Evanoff
Journal:  Am J Ind Med       Date:  2008-12       Impact factor: 3.079

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.